Click image to enlarge
The
U-PLEX platform offers validated components that can be combined to create high quality assays quickly and easily. The U-PLEX Human TNF-RI 384-well Assay has the essential components for an assay that measures TNF-RI in a single-analyte format on 384-well plates. For information on multiplexing TNF-RI with other analytes, please see
U-PLEX Custom Immuno-Oncology Group 1 (human) Assays.
Related Key Terms: Tumor necrosis factor-α receptor 1, CD120a, FPF, TNF-R-I, TNF-R55, TNF-alphaR1, TNFAR, TNFR60, TNFRp55, TNFalpha-R1, Tnfr-2, Tnfr1, p55, p55-R, apoptosis, differentiation, proliferation
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Oncology & Cancer
|
|
|
Analyte(s)
|
|
TNF-RI
|
|
|
Species
|
|
Human
|
|
|
Instrument(s)
|
|
MESO SECTOR S 600
,
SECTOR Imager 6000
,
MESO SECTOR S 600MM
|
|
|
U-PLEX Group Compatibility
|
|
Immuno-Oncology Group 1
|
|
|
Plate Type
|
|
384-well
|
|
|
Capture Antibody
|
|
Mouse Monoclonal
|
|
|
Detection Antibody
|
|
Mouse Monoclonal
|
|
|
LLOD (Sensitivity)
|
|
0.15 pg/mL
|
|
|
Dynamic Range
|
|
0.15 - 1,000 pg/mL
|
|
|
Sample Type
|
|
EDTA Plasma, Normal Lysate, Plasma, Serum, Tumor Lysate
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Gene ID(s)
|
|
7132
|
|
|
UniProt ID(s)
|
|
P19438
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
|
2-8 °C
|
1 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
5 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
5 each
(1 plate)
|
|
|
|
|
2-8 °C
|
1 bottle
(200 mL)
|
|
|
|
|
≤-10 °C
|
2 bottle
(40 mL)
|
|
|
|
|
≤-10 °C
|
2 bottle
(50 mL)
|
|
|
|
|
RT
|
1 bottle
(90 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
|
2-8 °C
|
5 each
(5 plate size)
|
|
|
|
|
2-8 °C
|
25 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
25 each
(1 plate)
|
|
|
|
|
2-8 °C
|
5 bottle
(200 mL)
|
|
|
|
|
≤-10 °C
|
10 bottle
(40 mL)
|
|
|
|
|
≤-10 °C
|
10 bottle
(50 mL)
|
|
|
|
|
RT
|
5 bottle
(90 mL)
|
|
|
|
Product Inserts
|
|
|
|
Datasheets
|
|
|
|
Product Highlights
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
|
|
|
|
Kinetics and Biomarkers of Severe Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor-modified T Cell Therapy.
|
|
|
|
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study.
|
|
|
|
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis.
|
|
|
|
Inflammation biomarkers in vaginal fluid and preterm delivery.
|
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters